What is Emergent Biosolutions's free cash flow yield?

Emergent Biosolutions (EBS) reported free cash flow yield of 32.9% in Q1 2026.

What is the long-term trend for Emergent Biosolutions's free cash flow yield?

Over 2 years (2020 to 2025), Emergent Biosolutions's free cash flow yield has grown at a 74.8% compound annual growth rate (CAGR), from 8.2% to 25%.

What does free cash flow yield mean?

Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.

Emergent Biosolutions EBS Free cash flow yield

Free cash flow yield at other companies

Thermo Fisher ScientificTMO

3.7%+0.1pp

Regeneron PharmaceuticalsREGN

5%+0.6pp

AMP

Amphastar PharmaceuticalsAMPH

15.2%+4.3pp

Amneal Pharmaceuticals, Inc.AMRX

6.1%-3.5pp

CorMedixCRMD

36.3%+33.4pp

Collegium Pharmaceutical, Inc.COLL

31.4%+10.0pp

Other financials

Income statement

See full

Revenue$156.1M-29.7%

Gross profit$84.1M-37.1%

Operating income$10.5M-79.0%

Net income$6.8M-90.0%

EPS (diluted)$0.07-94.1%

Balance sheet

See full

Cash & equivalents$161.5M+5.7%

Total debt$584.6M-13.1%

Total equity$523.1M-5.4%

Total assets$1.3B-7.4%

Cash flow

See full

Operating cash flow-$33.8M-202%

CapEx$2.4M-33.3%

Free cash flow-$36.2M-145%

Valuation

See full

Market cap$411.74M+22.0%

Enterprise value$834.84M-2.6%

P/E3.6×—

P/S0.6×+0.3×

Profitability

See full

Gross margin54.2%+19.0pp

Operating margin15%+10.3pp

Net margin9.6%+5.8pp

FCF margin20.8%—

Returns & leverage

See full

Return on equity13.9%+8.1pp

Debt / equity1.1×-0.1×

Current ratio4.3×-2.0×

Where this comes from

Calculated from Emergent Biosolutions’s reported figures.

free cash flow/market cap=32.9%

Based on trailing twelve months.

The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Emergent Biosolutions's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Emergent Biosolutions's free cash flow yield?: Emergent Biosolutions (EBS) reported free cash flow yield of 32.9% in Q1 2026.
What is the long-term trend for Emergent Biosolutions's free cash flow yield?: Over 2 years (2020 to 2025), Emergent Biosolutions's free cash flow yield has grown at a 74.8% compound annual growth rate (CAGR), from 8.2% to 25%.
What does free cash flow yield mean?: Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.